GLP-1 Drugs May Weaken Muscles in Older Adults Despite Preserving Muscle Mass
New research reveals GLP-1 medications like semaglutide may reduce muscle strength in older adults, even when muscle mass appears preserved.
157 articles in this topic
New research reveals GLP-1 medications like semaglutide may reduce muscle strength in older adults, even when muscle mass appears preserved.
New expert recommendations show how targeting prediabetes early can prevent progression to diabetes and reduce cardiovascular complications.
ApoB and lipoprotein A emerge as superior predictors of cardiovascular risk compared to traditional LDL cholesterol measurements.
New research reveals pulmonary arterial hypertension involves systemic metabolic dysfunction across multiple organs and immune cells.
New research reveals how adipose tissue develops resistance to fat-burning signals, making weight loss increasingly difficult.
Scientists discover how PDAP1 protein reprograms liver cells to burn less fat and make more, driving hepatocellular carcinoma progression.
Massive study reveals protein and metabolite signatures that could detect heart, kidney, eye and nerve damage before symptoms appear.
New study shows fasted morning resistance training produces more consistent glucose responses than fed afternoon sessions.
Study reveals people with young-onset diabetes incur dramatically higher medical costs when chronic kidney disease emerges.
Study reveals how multiple genes interact to influence blood sugar control in GCK-MODY diabetes, affecting diagnosis timing.
Finnish study identifies distinct metabolic signatures for different genetic diabetes risk patterns, opening doors to personalized prevention.
New research reveals hypoglycemia after glucose tolerance tests in some type 2 diabetes patients with higher insulin sensitivity.